Refractory insulin resistance and hemophagocytic lymphohistiocytosis following enfortumab vedotin treatment: A case report.

Auteurs

Rossignon P, Nguyen LDK, Boegner P, Ku J, Herpain A

  • Date de publication

    June 2024

  • Type

    Other

  • Review

    Mol Clin Oncol

  • Researcher's name

    KU Jade

  • Hôpital

    Hôpital Erasme

  • Service

    Hématologie

  • PMID

    38799283

  • DOI

    10.3892/mco.2024.2742